Treatment of Acute Migraine With Subcutaneous Sumatriptan Roger K. Cady, MD; Jeanette K. Wendt, MD; John R. Kirchner, MD; John F. Rothrock, MD; Harold Skaggs, Jr, MD Joseph D. Sargent, MD;

First Page		Document Content
Date: 2014-06-09 19:14:40 Chemistry Headaches GlaxoSmithKline Migraine Sumatriptan Cluster headache Aspirin Placebo Dihydroergotamine Triptans Medicine Organic chemistry		Treatment of Acute Migraine With Subcutaneous Sumatriptan Roger K. Cady, MD; Jeanette K. Wendt, MD; John R. Kirchner, MD; John F. Rothrock, MD; Harold Skaggs, Jr, MD Joseph D. Sargent, MD; Add to Reading List Source URL: www.mywellcarepharmacy.com Download Document from Source Website File Size: 1,44 MB Share Document on Facebook

	The Pathway CH-2 Study Frequent Questions 1. What is the Pathway CH-2 Study? Headache treatment centers throughout the U.S. are participating in the Pathway CH-2 cluster headache clinical study. The study is for individu DocID: 1xUR2 - View Document
	Microsoft Word - Iranian visiting professor-final report DocID: 1qUqS - View Document
	Sumavel_4.6mg_Logo_KO.eps DocID: 1qPSD - View Document
	Microsoft Word - CH SIG members DocID: 1q7At - View Document
	EUROPEAN MIGRAINE DAY OF ACTION 2014 – MIGRAINE IN MEN DocID: 1otqO - View Document